Sotera Health Q3 Adjusted EPS USD 0.29 Vs. IBES Estimate USD 0.27

By Reuters News

Nov 03 (Reuters) - Sotera Health Q3 pretax profit USD 83.732 million vs. IBES estimate USD 101.4 million.

  • Q3 revenue USD 324.886 million vs. IBES estimate USD 319.8 million
  • Q3 net income USD 58.391 million
  • Q3 gross profit USD 180.789 million
  • outlook FY adjusted EBITDA growth 5.75-7.25%
  • outlook FY revenue growth 5.25-6.75%

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.